Erratum to: Int Urogynecol J
DOI 10.1007/s00192-009-0903-0
Incorrect data were given for the prevalence of clinically relevant POP. The correct overall presence of clinically relevant POP (≥ stage 2B) was 17.5% (n=114). Within this group, 30.7% (n=35) were symptomatic.
Furthermore, Table 4 was presented without the accompanying prognostic curve.
Table 4.
The Slieker POP score chart and the prognostic index to read the sum score
The authors sincerely regret these errors.
Footnotes
The online version of the original article can be found at http://dx.doi.org/10.1007/s00192-009-0903-0.

